Watch XENE. Know when insiders buy.
One email the day a filing lands. Free.
XENE
Xenon Pharmaceuticals Inc.
35.95
−0.32 −0.88%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
54
WATCH · insiders 85, shorts 23
Insiders, 90 days
+$1.3M
net buying · 2 buys, 2 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.5BP/E —DIV YIELD —FCF YIELD -9.72%REV TTM —NET INCOME −$409.2MNET CASH $93M52W 33.49 – 70.96NEXT EARNINGS Nov 2SEC XBRL · TTM TO Invalid Date
Insider trading
+$1.3M
Net, 90 days
2 / 2
Buys / sells, 90 days
2
Distinct buyers
$1.7M
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 30 | Oct 1 | MORTIMER IAN · PRESIDENT & CEO | Buy | 30,000 | $37.38 | $1.1M |
| Sep 30 | Oct 1 | Kelly Thomas Patrick · Chief Financial Officer | Buy | 15,000 | $37.32 | $560K |
| Aug 28 | Aug 31 | KENNEY CHRISTOPHER JOHN · Chief Medical Officer | Sell | 700 | $60.98 | $43K |
| Aug 28 | Aug 31 | KENNEY CHRISTOPHER JOHN · Chief Medical Officer | Sell | 6,368 | $60.17 | $383K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.